| 中文名 | (8S,10S)-10-[(3-氨基-2,3,6-三脱氧-ALPHA-L-吡喃来苏己糖基)氧基]-8-(2-溴-1,1-二甲氧基乙基)-7,8,9,10-四氢-6,8,11-三羟基-1-甲氧基-5,12-并四苯醌 |
|---|---|
| 英文名 | (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-(2-bromo-1,1-dimethoxyethyl)-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
| 中文别名 |
DOXORUBICIN KETAL 杂质
(8S,10S)-10-(((2R,4S,5S,6S)-4-氨基-5-羟基-6-甲基四氢-2H-吡喃-2-基)氧基)-8-(2-溴- 1,1-二甲氧基乙基)-6,8,11-三羟基-1-甲氧基-7,8,9,10-四氢并四苯-5,12-二酮 (多柔比星杂质) 多柔比星杂质B 阿霉素杂质2(阿霉素杂质B) 表柔比星溴缩酮 阿霉素杂质B 多柔比星杂质02(单体) 盐酸多柔比星杂质B |
| 英文别名 |
Doxorubicin Hydrochloride impurity B
Doxorubicin Impurity B Doxorubicin Ketal Derivative Doxorubicin Ketal Impurity 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S) (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-broMo-1,1-diMethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-5,12-naphthacenedione (Doxorubicin IMpurity) UNII-3Z1AE1LY2D (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-bromo-1,1-dimethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-bromo-1,1-dimethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione (Doxorubicin Impurity) (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Doxorubicin Impurity 2(Doxorubicin Impurity B) (8S,10S)-10[(3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Daunorubicin bromoketal Daunorubicin bromo dimethyl ketal 14-bromo-13-dimethylketal-daunorubicin |
| 分子式 | C29H34BrNO11 |
|---|---|
| 分子量 | 652.48400 |
| 精确质量 | 651.13200 |
| PSA | 187.23000 |
| LogP | 2.52420 |
| 上游产品 3 | |
|---|---|
| 下游产品 0 | |